All decks Close
All decks 19
  • Modern LINAC-Based Radiotherapy for Pituitary Adenomas

    Journal club presentation on outcomes of modern linear accelerator-based radiotherapy for secretory and nonsecretory pituitary adenomas

  • Conformal Radiation Therapy for Pediatric Ependymoma: The ACNS0121 Trial

    Journal club presentation on the Children's Oncology Group ACNS0121 phase 3 trial for pediatric ependymoma

  • Conformal Radiation Therapy for Pediatric Ependymoma: The ACNS0121 Trial

    Journal club presentation on the Children's Oncology Group ACNS0121 phase 3 trial for pediatric ependymoma

  • High-dose Proton Beam Therapy vs Conventional Radiation Therapy for Newly Diagnosed Glioblastoma

    Journal club presentation of Matsuda et al. Radiation Oncology (2023) 18:38

  • Joint Final Report of EORTC 26951 and RTOG 9402: PCV Chemotherapy for Anaplastic Oligodendroglial Tumors

    Journal club presentation on the final very long-term survival results of two phase III trials for anaplastic oligodendroglial tumors

  • Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors

    Journal club presentation on Zhao et al. Radiation Oncology 2020

  • Targeting Beyond the Tumor: Radiation's Evolving Role in Oncogene-Driven Lung Cancer

    Explore the exciting advancements in targeted therapies for oncogene-driven lung cancer, highlighting novel approaches and trial results that promise to redefine treatment strategies and improve patient outcomes. Discover what the future holds!

  • VISION Trial: QOL and Pain Outcomes with [177Lu]Lu-PSMA-617 in mCRPC

    Journal club presentation on quality of life outcomes from the VISION phase 3 trial

  • Treatment Options for Low & Favorable Intermediate Risk Prostate Cancer - Part 1

    Evidence-based review of management options - surgical management and early trials

  • ARTDECO: Dose Escalation in Definitive Chemoradiation for Esophageal Cancer

    Journal club presentation on the ARTDECO phase 3 randomized trial

  • AHOD0431: PET-adapted therapy for early-stage, low-risk pediatric Hodgkin lymphoma

    AHOD0431 trial, exploring PET-adapted therapy for low-risk pediatric Hodgkin lymphoma, with insights into patient outcomes, relapse patterns, and comparisons to existing studies.

  • AHL2011: PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma

    Journal club presentation on the AHL2011 phase 3 randomized trial

  • Radiation Therapy for Localized MALT Lymphoma: Long-Term Outcomes

    Journal club presentation on a prospective trial of radiation therapy for localized mucosa-associated lymphoid tissue (MALT) lymphoma

  • FoRT Trial: 4 Gy vs 24 Gy Radiotherapy for Follicular and Marginal Zone Lymphoma

    Journal Club Presentation on the FoRT Trial by Hoskin et al.

  • Postoperative Chemoradiation for High-Risk Head and Neck Cancer

    A comparative analysis of EORTC #22931 and RTOG #9501 trials

  • deck

  • Copy of deck

  • deck

  • deck